Abbott Laboratories (ABT)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
At close: 04:02PM EST
After hours:
| Previous Close | 120.44 |
| Open | 120.77 |
| Bid | 125.00 x 800 |
| Ask | 125.50 x 1200 |
| Day's Range | 119.61 - 125.53 |
| 52 Week Range | 105.36 - 142.60 |
| Volume | |
| Avg. Volume | 6,037,461 |
| Market Cap | 221.655B |
| Beta (5Y Monthly) | 0.70 |
| PE Ratio (TTM) | 31.81 |
| EPS (TTM) | 3.94 |
| Earnings Date | Apr. 18, 2022 - Apr. 22, 2022 |
| Forward Dividend & Yield | 1.88 (1.57%) |
| Ex-Dividend Date | Jan. 13, 2022 |
| 1y Target Est | 144.18 |
- Motley Fool
Abbott Laboratories (ABT) Q4 2021 Earnings Call Transcript
It cannot be recorded or rebroadcast without Abbott's expressed written permission. With me today are Robert Ford, chairman and chief executive officer; and Bob Funck, executive vice president, finance and chief financial officer. Abbott cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements.
- Zacks
Abbott's (ABT) Q4 Earnings and Revenues Beat Estimates
Abbott's (ABT) COVID-19 testing-related sales in Q4 increased on demand for BinaxNOW, Panbio and ID NOW rapid testing platforms.
- Zacks
Abbott (ABT) Q4 Earnings and Revenues Surpass Estimates
Abbott (ABT) delivered earnings and revenue surprises of 11.86% and 8.52%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
